Dott. Luigi Vicari on marzo 19th, 2010

Just like older-generation antidepressants, selective serotonin reuptake inhibitors (SSRIs) have been associated with an increased risk for cataracts, new research shows. Leggi l’articolo intero.

Continue reading about SSRIs May Boost Risk for Cataracts

Adding heft to the hypothesis that vitamin-D deficiency is linked to cardiovascular disease, a new study has found that people with low vitamin-D levels who managed to normalize their levels were significantly less likely to develop cardiovascular events over up to six years of follow-up. Leggi l’articolo intero.

Continue reading about Death, Cardiovascular Disease Risk Declines in People Who “Normalize” Vitamin-D Levels

Simvastatin (Zocor, Merck/Schering-Plough Pharmaceuticals), used at the highest approved dose of 80 mg, is associated with an increased risk for myopathy, including rhabdomyolysis, according to the US Food and Drug Administration (FDA).

Continue reading about High-Dose Simvastatin Associated With Increased Risk for Myopathy, FDA Warns